TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -15.58%200.08M | 6.72%494.26M | 11.85%237.01M | 27.26%463.12M | 6.09%211.9M | 182.39%363.92M | 266.48%199.73M | -27.00%128.87M | -39.77%54.5M | 14.11%176.53M |
Operating income | -15.58%200.08M | 6.72%494.26M | 11.85%237.01M | 27.26%463.12M | 6.09%211.9M | 182.39%363.92M | 266.48%199.73M | -27.00%128.87M | -39.77%54.5M | 14.11%176.53M |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Employee expense | 18.96%-74.17M | -3.58%-183.82M | -11.08%-91.52M | -41.58%-177.46M | -46.21%-82.39M | -76.81%-125.34M | -72.19%-56.35M | 13.39%-70.89M | 11.50%-32.73M | -52.32%-81.84M |
Depreciation and amortization | 7.71%-19.26M | 4.53%-42.44M | 3.84%-20.87M | -79.25%-44.45M | -195.59%-21.7M | -91.17%-24.8M | -14.75%-7.34M | -5.15%-12.97M | -6.74%-6.4M | -9.93%-12.34M |
Special items of operating profit | 26.24%-102.3M | -5.05%-274.63M | -36.31%-138.7M | -45.60%-261.42M | -36.96%-101.75M | -202.38%-179.55M | -237.04%-74.29M | 7.90%-59.38M | 31.76%-22.04M | -1.76%-64.47M |
Operating profit | 130.86%4.34M | 67.21%-6.63M | -332.58%-14.08M | -159.04%-20.21M | -90.20%6.05M | 338.22%34.23M | 1,026.11%61.74M | -180.36%-14.37M | -143.84%-6.67M | -32.24%17.88M |
Financing cost | -0.90%-2.58M | -40.85%-5.16M | -46.93%-2.56M | -20.91%-3.66M | -47.92%-1.74M | -63.71%-3.03M | -20.10%-1.18M | 16.37%-1.85M | 16.31%-980K | ---2.21M |
Earning before tax | 110.60%1.76M | 50.64%-11.78M | -485.85%-16.63M | -176.49%-23.87M | -92.88%4.31M | 292.40%31.2M | 892.04%60.57M | -203.50%-16.22M | -154.49%-7.65M | -40.62%15.67M |
Tax | -166.77%-2.39M | -124.84%-836K | 498.22%3.58M | 157.84%3.37M | 86.46%-900K | -263.27%-5.82M | -555.97%-6.65M | 268.67%3.56M | 158.34%1.46M | 53.98%-2.11M |
After-tax profit from continuing operations | 95.17%-630K | 38.46%-12.62M | -482.59%-13.05M | -180.77%-20.5M | -93.67%3.41M | 300.60%25.38M | 971.21%53.92M | -193.34%-12.65M | -153.65%-6.19M | -37.81%13.56M |
Earning after tax | 95.17%-630K | 38.46%-12.62M | -482.59%-13.05M | -180.77%-20.5M | -93.67%3.41M | 300.60%25.38M | 971.21%53.92M | -193.34%-12.65M | -153.65%-6.19M | -37.81%13.56M |
Profit attributable to shareholders | 95.17%-630K | 38.46%-12.62M | -482.59%-13.05M | -180.77%-20.5M | -93.67%3.41M | 300.60%25.38M | 971.21%53.92M | -193.34%-12.65M | -153.65%-6.19M | -37.81%13.56M |
Basic earnings per share | 95.09%-0.0016 | 38.60%-0.0315 | -483.53%-0.0326 | -180.79%-0.0513 | -93.69%0.0085 | 300.95%0.0635 | 969.68%0.1348 | -0.0316 | -153.82%-0.0155 | |
Diluted earnings per share | 95.09%-0.0016 | 38.60%-0.0315 | -483.53%-0.0326 | -180.79%-0.0513 | -93.69%0.0085 | 300.95%0.0635 | 969.68%0.1348 | -0.0316 | -153.82%-0.0155 | |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.